Am J Perinatol 2005; 22(4): 223-225
DOI: 10.1055/s-2005-866605
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Thrombotic Thrombocytopenic Purpura in a Patient with Acquired Immunodeficiency Syndrome at 28 Weeks Gestation

David M. Sherer1 , Jasotha Sanmugarajah1 , Mudar Dalloul1 , Sarah M. Temkin1 , John Thanus1 , Ovadia Abulafia1
  • 1Divisions of Maternal-Fetal Medicine and Gynecologic Oncology, Departments of Obstetrics and Gynecology and Hematology Oncology, State University of New York (SUNY), Downstate Medical Center, Brooklyn, New York
Further Information

Publication History

Publication Date:
02 May 2005 (online)

ABSTRACT

An increased incidence of thrombotic thrombocytopenic purpura has been reported among human immunodeficiency virus-infected patients or those with acquired immunodeficiency syndrome (AIDS). Despite this association, hitherto only a single case of thrombotic thrombocytopenic purpura has been reported in an HIV-infected patient during pregnancy. We describe a young multiparous patient with long-standing AIDS who presented with lower abdominal pain. Following findings of thrombocytopenia, microangiopathic hemolytic anemia, renal failure, low-grade fever, and mental status changes, thrombotic thrombocytopenic purpura was diagnosed after initially considering the diagnosis of severe preeclampsia, and the patient was delivered by cesarean section. The patient required multiple plasma exchanges during a protracted postpartum course, and was discharged in good health. This first report of thrombotic thrombocytopenic purpura and AIDS in pregnancy demonstrates that when encountering preeclampsia in patients with AIDS, thrombotic microangiopathy should be strongly considered. In addition, these patients may exhibit an attenuated response to plasma exchange therapy and despite previous reports in nonobstetric patients, a favorable outcome is attainable in these critically ill patients.

REFERENCES

  • 1 Nabhan C, Kwaan H C. Current concepts in the diagnosis and management of thrombotic thrombocytopenic purpura.  Hematol Oncol Clin North Am. 2003;  17 177-199
  • 2 Segal G H, Tubbs R R, Ratliff N B, Miller M L, Longworth D L. Thrombotic thrombocytopenic purpura in a patient with AIDS.  Cleve Clin J Med. 1990;  57 360-366
  • 3 Ucar A, Fernandez H F, Byrnes J J, Lian E C, Harrington W J. Thrombotic microangiopathy and retroviral infections: a 13-year experience.  Am J Hematol. 1994;  45 304-309
  • 4 Sood R, Rakkar A S, Carmosino L, Mir T, Khan F A. Thrombotic thromobocytopenic purpura in HIV infection: a report of two cases.  AIDS Patient Care STDS. 1996;  10 349-352
  • 5 Sutor G C, Schmidt R E, Albrecht H. Thrombotic microangiopathies and HIV infection: report of two typical cases, features of HUS and TTP and review of the literature.  Infection. 1999;  27 12-15
  • 6 Ranzini A C, Chavez M R, Ghigliotty B, Porcelli M. Thrombotic thrombocytopenic purpura and human immunodeficiency virus complicating pregnancy.  Obstet Gynecol. 2002;  100 1133-1136
  • 7 Gadallah M F, el-Shahawy M A, Campese V M, Todd J R, King J W. Disparate prognosis of thrombotic microangiopathy in HIV-infected patients with and without AIDS.  Am J Nephrol. 1996;  16 446-450
  • 8 Wimalasundera R C, Laralestier N, Smith J H et al.. Pre-eclampsia, antiretroviral therapy, and immune reconstitution.  Lancet. 2002;  360 1152-1154
  • 9 Frank K A, Buchmann E J, Schackis R C. Does human immunodeficiency virus infection protect against preeclampsia-eclampsia?.  Obstet Gynecol. 2004;  104 238-242

David M ShererM.D. 

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, State University of New York (SUNY), Downstate Medical Center

450 Clarkson Avenue, Box 24, Brooklyn, NY 11203